We will be updating this page regularly with support and resources for the life sciences community
Alongside MedCity, advice and support for researchers and innovators is available from national life sciences and healthcare bodies.
ABHI is guiding the HealthTech community to support the national effort to provide life-saving health technologies to patients
ABPI is working closely with the Department of Health and the NHS on how our members can best support the Government as plans evolve
The AHSN Network is part of a coordinated NHS response to identify and enable the implementation of technologies that respond to the developing COVID-19 pandemic, in particular solutions for remote consultation and patient monitoring, diagnostics and point-of-care testing.
If you are a company or an innovator with a potential COVID-19 related solution, please contact the relevant national agency direct:
- Vaccines: Nervtag@phe.gov.uk
- Ventilators: 0300 456 3565 / firstname.lastname@example.org
- Diagnostics: email@example.com
- Innovation & Technology: DNHSX@nhsx.nhs.uk
BioIndustry Association, the trade association for innovative life sciences in the UK
KTN is working with Innovate UK and other organisations to connect those able to respond or adapt to the UK’s new challenges
MHRA is prioritising work supporting and authorising the development of vaccines, clinical trials of new medicines and managing the supply of medicines and healthcare products.
MHRA Clinical trials helpline: Clintrialhelpline@mhra.gov.uk
NICE has developed rapid guidelines and evidence reviews
UKRI has two priorities: the safety and wellbeing of their workforce and, as far as possible, the continuation of business as a national funder of research and innovation.
Vaccines – firstname.lastname@example.org
Increasing testing and diagnostic capacity: Coviddiagnostics@phe.gov.uk
There are also efforts to encourage collaboration, including through a UK-based open innovation network for universities, research organisations, and businesses, CrowdHelix. They are seeking researchers & innovators worldwide with a strong track record of excellence in fields relevant to the global effort to tackle the novel coronavirus (COVID-19) pandemic.
Please see here for a regularly updated list of funding opportunities.